CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 34 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $72,000 | -36.3% | 315,927 | 0.0% | 0.00% | – |
| Q4 2017 | $113,000 | -37.2% | 315,927 | -8.9% | 0.00% | – |
| Q3 2017 | $180,000 | -10.4% | 346,720 | 0.0% | 0.00% | – |
| Q2 2017 | $201,000 | -67.9% | 346,720 | -2.0% | 0.00% | – |
| Q1 2017 | $626,000 | +50.5% | 353,777 | +2.0% | 0.00% | – |
| Q4 2016 | $416,000 | +235.5% | 346,720 | +198.3% | 0.00% | – |
| Q3 2016 | $124,000 | +3.3% | 116,229 | 0.0% | 0.00% | – |
| Q2 2016 | $120,000 | -14.3% | 116,229 | 0.0% | 0.00% | – |
| Q1 2016 | $140,000 | -21.3% | 116,229 | 0.0% | 0.00% | – |
| Q4 2015 | $178,000 | +13.4% | 116,229 | +53.8% | 0.00% | – |
| Q3 2015 | $157,000 | +19.8% | 75,588 | +192.6% | 0.00% | – |
| Q2 2015 | $131,000 | – | 25,833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 1,132,737 | $1,399,000 | 0.21% |
| Prospera Financial Services Inc | 177,550 | $215,000 | 0.05% |
| LBA Wealth Management, LLC | 12,000 | $15,000 | 0.01% |
| Cambridge Investment Research Advisors, Inc. | 23,457 | $28,000 | 0.00% |
| TIAA CREF INVESTMENT MANAGEMENT LLC | 313,801 | $866,000 | 0.00% |
| TEACHERS ADVISORS, LLC | 148,551 | $410,000 | 0.00% |
| Balentine LLC | 55 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 177 | $0 | 0.00% |
| Vantage Investment Advisors, LLC | 1,150 | $1,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 5,453 | $7,000 | 0.00% |